Author

M. van der Vlist

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:comparative / phylogenetic analysis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

L. Meyaard· 3 shared C. Kesmir· 2 shared M. I. Pascoal Ramos· 2 shared A. Miranda Bedate· 1 shared A. Singh· 1 shared A. Yermanos· 1 shared E. D. Kaan· 1 shared F. M. A. Peters· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

L. Meyaard

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets

A. Singh, A. Miranda Bedate, H. J. Von Richthofen, S. V. Vijver, M. van der Vlist, R. Kuhn, A. Yermanos, J. J. Kuball, C. Kesmir, M. I. Pascoal Ramos, L. Meyaard

The paper introduces a bioinformatics pipeline to identify known and putative immune inhibitory receptors as therapeutic targets using machine learning and transcriptomics data.

bioRxiv · Oct 24, 2023Immunology

Identification of a novel conserved signaling motif in CD200 Receptor required for its inhibitory function

L. M. Timmerman, J. F. de Graaf, N. Satravelas, C. Kesmir, L. Meyaard, M. van der Vlist

The paper identifies a unique conserved signaling motif in CD200R that mediates its inhibitory function, distinct from the common NPxY motif.

bioRxiv · Dec 17, 2020Immunology

Inhibitory CD200-receptor signaling is rewired by type I interferon

M. van der Vlist, M. I. Pascoal Ramos, L. L. van den Hoogen, S. Hiddingh, L. Timmerman, T. A. P. de Hond, E. D. Kaan, M. van der Kroef, R. J. Lebbink, F. M. A. Peters, W. Khoury-Hanold, R. Fritsch-Stork, T. Radstake, L. Meyaard

This study shows that type I interferon alters CD200R signaling by promoting RasGAP cleavage, converting CD200R from an inhibitor to a potentiator of IFNG mRNA production in SLE patients.

bioRxiv · Feb 6, 2020Immunology